Xiaoyang Li
- Molecular Biology
- Pharmacology top 2%
- Pharmacology top 2%
- Immunology
- Oncology
- Co-authors
- Jia‐Wen ShouZhenxiong ZhaoShengji YuBao‐Ying WenJian‐Dong JiangYuan LinChi‐Yu HeQian Tong
- Topics
- Sarcoma Diagnosis and Treatment (6 papers)Berberine and alkaloids research (5 papers)Immunotherapy and Immune Responses (3 papers)
- Cited by
- PharmacologyBiological Psychiatry
- Journals
- Nano LettersACS NanoBiomaterials
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Xiaoyang Li
27 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 109
- Molecular Biology 680
- Pharmacology 409
- Pharmacology 263
- Immunology 131
- Oncology 112
Countries citing papers authored by Xiaoyang Li
This map shows the geographic impact of Xiaoyang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoyang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoyang Li more than expected).
Fields of papers citing papers by Xiaoyang Li
This network shows the impact of papers produced by Xiaoyang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoyang Li. The network helps show where Xiaoyang Li may publish in the future.
Co-authorship network of co-authors of Xiaoyang Li
This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoyang Li. A scholar is included among the top collaborators of Xiaoyang Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoyang Li. Xiaoyang Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 11 | |
| 4 | 3 | |
| 5 | 1 | |
| 6 | 8 | |
| 7 | 11 | |
| 8 | 3 | |
| 9 | 1 | |
| 10 | 2 | |
| 11 | 20 | |
| 12 | 8 | |
| 13 | 100 | |
| 14 | Oral berberine improves brain dopa/dopamine levels to ameliorate Parkinson’s disease by regulating gut microbiotabreakdown → | 240 |
| 15 | 160 | |
| 16 | 6 | |
| 17 | 8 | |
| 18 | 14 | |
| 19 | 243 | |
| 20 | 60 |
About Xiaoyang Li
Xiaoyang Li is a scholar working on Pharmacology, Pharmacology and Cancer Research, having authored 29 papers that have together received 1.2k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (6 papers), Berberine and alkaloids research (5 papers) and Immunotherapy and Immune Responses (3 papers). The work is most often cited by research in Pharmacology (263 citations), Biological Psychiatry (67 citations) and Pharmacology (409 citations). Xiaoyang Li has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Jia‐Wen Shou, Zhenxiong Zhao, Shengji Yu, Bao‐Ying Wen, Jian‐Dong Jiang, Yuan Lin, Chi‐Yu He, Qian Tong, Ru Feng and Jie Fu. Their work appears in journals such as Nano Letters, ACS Nano and Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.